Interim positron emission tomography in early stage Hodgkin lymphoma: is there evidence for its prognostic and predictive value in patients treated with standard combined modality treatment?

By Specht Lena  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1127-1128

Informa Healthcare

Access to resources Recommend Favorite

Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy

By Hodgson D.C.   Tsang R.W.   Pintilie M.   Sun A.   Wells W.   Crump M.   Gospodarowicz M.K.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1374-1381

Elsevier

Access to resources Recommend Favorite

Risk of second malignancies in patients with early‐stage classical Hodgkin's lymphoma treated in a modern era

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 513-518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positron Emission Tomography for the Staging of Hodgkin's Lymphoma - Increasing the Body of Evidence in Favor of the Method

By Menzel Christian   Döbert Natascha   Mitrou Paris   Mose Stefan   Diehl Michaela   Berner Uwe   Grünwald Frank  

Acta Oncologica, Vol. 41, Iss. 5, 2002-09 ,pp. : 430-436

Informa Healthcare

Access to resources Recommend Favorite

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 307-308

Informa Healthcare

Access to resources Recommend Favorite